Lindbrook Capital LLC decreased its position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,887 shares of the company’s stock after selling 180 shares during the quarter. Lindbrook […]